Objective To assess the extent and types of financial ties to industry of panel and task force members of the American Psychiatric Association’s Diagnostic and Statistical Manual of Mental Disorders , fifth edition, text revision (DSM-5-TR), published in 2022. Design Cross sectional analysis. Setting Open Payments database, USA. Participants 92 physicians based in the US who served as members of either a panel (n=86) or task force (n=6) on the DSM-5-TR with information recorded in the Centers for Medicare and Medicaid Services Open Payments database during 2016-19. This period was chosen to include the year that development of the DSM-5-TR began and the three years preceding, a time consistent with previous research on conflicts of interest and consistent with the American Psychiatric Association’s disclosure requirements for the fifth revision (DSM-5) of the manual. Main outcome measures Type and amount of compensation the panel and task force members of DSM-5-TR received during 2016-19. Results After duplicate names had been removed, 168 individuals were identified who served as either panel or task force members of the DSM-5-TR. 92 met the inclusion criteria of being a physician who was based in the US and therefore could be included in Open Payments. Of these 92 individuals, 55 (60%) received payments from industry. Collectively, these panel members received a total of $14.2m (£11.2m; €13m). One third (33.3%) of the task force members had payments reported in Open Payments. Conclusions Conflicts of interest among panel members of DSM-5-TR were prevalent. Because of the enormous influence of diagnostic and treatment guidelines, the standards for participation on a guideline development panel should be high. A rebuttable presumption should exist for the Diagnostic and Statistical Manual of Mental Disorders to prohibit conflicts of interest among its panel and task force members. When no independent individuals with the requisite expertise are available, individuals with associations to industry could consult to the panels, but they should not have decision making authority on revisions or the inclusion of new disorders. The raw data used in this study is publicly available at .

中文翻译：

---

DSM-5-TR 中未公开的财务利益冲突：横截面分析

目的 评估 2022 年出版的美国精神病学协会精神疾病诊断和统计手册第五版文本修订版 (DSM-5-TR) 小组和工作组成员与行业的财务联系的程度和类型。 Design Cross截面分析。设置开放支付数据库，美国。参与者 92 名美国医生，他们是 DSM-5-TR 小组 (n=86) 或工作组 (n=6) 的成员，其信息记录在医疗保险和医疗补助服务中心开放支付数据库中2016-19。该时期被选择为包括 DSM-5-TR 开始开发的年份和之前的三年，该时间与之前有关利益冲突的研究一致，并符合美国精神病学协会第五次修订版的披露要求（DSM-5-TR）。 5) 手册。主要成果衡量 DSM-5-TR 小组和工作组成员在 2016-19 年期间收到的补偿类型和金额。结果 删除重复姓名后，确定了 168 名个人担任 DSM-5-TR 小组或工作组成员。92 符合美国医生的纳入标准，因此可以纳入开放式付款。在这 92 人中，55 人（60%）收到了来自行业的付款。这些小组成员总共获得了 1,420 万美元（1,120 万英镑；1,300 万欧元）的奖金。三分之一 (33.3%) 的工作组成员在公开付款中报告了付款情况。结论 DSM-5-TR 小组成员之间普遍存在利益冲突。由于诊断和治疗指南的巨大影响，指南制定小组的参与标准应该很高。《精神疾病诊断和统计手册》应存在可反驳的推定，以禁止其专家组和工作组成员之间的利益冲突。当没有具备必要专业知识的独立个人时，与行业协会相关的个人可以向专家组咨询，但他们不应该拥有修订或纳入新疾病的决策权。本研究中使用的原始数据可公开获取：。